Skip to main content

Table 1 Baseline characteristics

From: Clinical impact of diabetes mellitus in patients undergoing transcatheter aortic valve replacement

  Non-diabetic (N = 285) Diabetic (N = 158) P-value
NIDDM (N = 114) IDDM (N = 44)
Age 81.8 ± 7.5 79.8 ± 7.5 79.4 ± 7.7 0.016
Male 128 (46) 53 (46) 23 (52) 0.71
Hemoglobin 11.5 (1.4) 11.6 (1.4) 12.6 (2.2) 0.18
Glucose 91 (13) 97 (21) 95 (34) 0.21
Renal dysfunction 46 (17) 21 (20) 23 (59) <0.001
Hypertension 232 (84) 103 (94) 34 (83) 0.032
Dyslipidemia 199 (72) 90 (83) 34 (85) 0.036
Coronary artery disease 124 (46) 48 (45) 24 (60) 0.22
CHF-NYHA class III–IV 165 (58) 62 (54) 23 (52) 0.64
Atrial fibrillation/flutter 66 (27) 29 (28) 13 (33) 0.71
Peripheral vascular disease 33 (12) 13 (12) 6 (15) 0.85
Current smoker 11 (4) 2 (2) 2 (5) 0.53
COPD 41 (15) 19 (18) 11 (28) 0.13
s/p CABG 57 (21) 22 (21) 10 (26) 0.8
s/p PCI 73 (27) 30 (29) 14 (36) 0.55
Pacemaker 21 (8) 7 (7) 2 (5) 0.79
STS mortality 5.3 ± 3.7 5.2 ± 2.9 7.6 ± 5.6 0.21
EUROSCORE 2 4.9 ± 5.1 4.7 ± 5.3 9.1 ± 8.7 0.16
HbA1c 5.7 ± 0.43 6.8 ± 1.00 7.9 ± 1.47 <0.001
  1. All values are expressed as mean ± SD or N (%)
  2. NIDDM non-insulin dependent diabetes mellitus, IDDM insulin dependent diabetes mellitus, CHF congestive heart failure, NYHA New York Heart Association, COPD chronic obstructive lung disease, CABG coronary artery bypass surgery, PCI percutaneous coronary intervention, STS Society of Thoracic Surgeons